Collectively, this study endeavors to delineate the altered landscape of glycogen metabolism within DKD and to further investigate the therapeutic potential of AA in mitigating DKD through the modulation of STBD1-mediated metabolic pathways. The gene discussed is STBD1; the disease is diabetic kidney disease.